Cite
Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)
MLA
Hayden, P. J., et al. “Management of Adults and Children Receiving CAR T-Cell Therapy: 2021 Best Practice Recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA).” Annals of Oncology, vol. 33, no. 3, Mar. 2022, pp. 259–75. EBSCOhost, https://doi.org/10.1016/j.annonc.2021.12.003.
APA
Hayden, P. J., Roddie, C., Bader, P., Basak, G. W., Bonig, H., Bonini, C., Chabannon, C., Ciceri, F., Corbacioglu, S., Ellard, R., Sanchez-Guijo, F., Jäger, U., Hildebrandt, M., Hudecek, M., Kersten, M. J., Köhl, U., Kuball, J., Mielke, S., Mohty, M., & Murray, J. (2022). Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA). Annals of Oncology, 33(3), 259–275. https://doi.org/10.1016/j.annonc.2021.12.003
Chicago
Hayden, P.J., C. Roddie, P. Bader, G.W. Basak, H. Bonig, C. Bonini, C. Chabannon, et al. 2022. “Management of Adults and Children Receiving CAR T-Cell Therapy: 2021 Best Practice Recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA).” Annals of Oncology 33 (3): 259–75. doi:10.1016/j.annonc.2021.12.003.